Halozyme Therapeutics Market Sentiment

SPY767.77−0.59%QQQ713.33−1.69%BTC/USD80,771.00−0.59%DIA521.54−0.60%GLD367.54−1.60%TLT81.37+0.47%

Premium Services

Halozyme Therapeutics Inc

HALONASDAQ

Trade with Public

$130.75

0.720.55%

Last update: Oct 29, 2:56 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Earnings: Q3 2026 Earnings in 7 days from now on Thu Nov 5th, after the market close

Conference Call: Conference call scheduled in 7 days at 4:30 PM

Click to view the webcast

Halozyme Therapeutics Market Sentiment - Benzinga

Halozyme Therapeutics Market Sentiment

Market sentiment signals for Halozyme Therapeutics (HALO): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Market Outperform

Short Interest▲ 15.8% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Market Outperform

16 analysts

Options Flow (P/C)

—

Avg Consensus PT

$86

-34.4%

Highest Price Target

$130

-0.6%

HC Wainwright & Co.

Lowest Price Target

$47

-64.1%

Leerink Partners

Short Interest

15.8%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 13, 2026	TD Cowen	Brendan Smith—	-0.6%	$105 → $130	Maintained	Buy
Oct 8, 2026	JP Morgan	Jessica Fye—	-40.3%	$70 → $78	Maintained	Neutral
Oct 8, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-0.6%	$115 → $130	Maintained	Buy
Sep 2, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-12.0%	$115 → $115	Maintained	Buy
Aug 7, 2026	Leerink Partners	David Risinger—	-15.9%	$83 → $110	Upgrade	Market Perform→Outperform
Aug 7, 2026	TD Cowen	Brendan Smith—	-19.7%	$96 → $105	Maintained	Buy
Aug 7, 2026	Citizens	Jason N. Butler—	-28.9%	$92 → $93	Maintained	Market Outperform
Aug 7, 2026	Wells Fargo	Mohit Bansal—	-27.3%	$75 → $95	Maintained	Equal-Weight
Aug 7, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-12.0%	$95 → $115	Maintained	Buy
Jul 21, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-27.3%	$95 → $95	Maintained	Buy
May 12, 2026	Morgan Stanley	Vikram Purohit—	-28.9%	$96 → $93	Maintained	Overweight
Apr 29, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-27.3%	$90 → $95	Maintained	Buy
Feb 19, 2026	Benchmark	Robert Wasserman—	-31.2%	$75 → $90	Maintained	Buy
Feb 19, 2026	Wells Fargo	Mohit Bansal—	-42.6%	$65 → $75	Maintained	Equal-Weight
Jan 8, 2026	TD Cowen	Brendan Smith—	-31.2%	$79 → $90	Maintained	Buy
Dec 19, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-31.2%	$90 → $90	Maintained	Buy
Nov 28, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-31.2%	$90 → $90	Maintained	Buy
Nov 18, 2025	Goldman Sachs	Graig Suvannavejh—	-57.2%	$54 → $56	Maintained	Neutral
Nov 4, 2025	Citizens	Jason Butler—	-29.6%	$91 → $92	Maintained	Market Outperform
Oct 27, 2025	JP Morgan	Jessica Fye—	-50.3%	$63 → $65	Maintained	Neutral
Oct 20, 2025	Morgan Stanley	Vikram Purohit—	-39.6%	$80 → $79	Maintained	Overweight
Oct 15, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-31.2%	$90 → $90	Maintained	Buy
Oct 14, 2025	Leerink Partners	David Risinger—	-46.5%	$70	Upgrade	Underperform→Market Perform
Oct 2, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	-31.2%	$85 → $90	Maintained	Buy
Sep 24, 2025	Benchmark	Robert Wasserman—	-31.2%	$75 → $90	Maintained	Buy